Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era.
Sean A FletcherMufaddal M MamawalaAlbert E HollerYasin BhanjiKatarzyna J MacuraClaire M de la CalleChristian P PavlovichPublished in: The Prostate (2024)
The CCLO score is a valid, objective metric to predict GR and receipt of treatment in a large AS cohort. The ability of the MRI-informed mCCLO to predict GR is on par with traditional metrics of tumor volume but is more descriptive and may benefit from greater reproducibility. The mCCLO score can be implemented as a shorthand, informative tool for counseling patients about whether to remain on AS.
Keyphrases
- magnetic resonance imaging
- end stage renal disease
- contrast enhanced
- prostate cancer
- newly diagnosed
- ejection fraction
- papillary thyroid
- peritoneal dialysis
- prognostic factors
- cross sectional
- computed tomography
- magnetic resonance
- type diabetes
- ultrasound guided
- adipose tissue
- squamous cell carcinoma
- patient reported outcomes
- metabolic syndrome
- smoking cessation
- young adults
- insulin resistance
- skeletal muscle